Genprex, Inc.
GNPX
$0.2861
-$0.0239-7.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.81% | -20.71% | -8.56% | -6.06% | 9.19% |
| Depreciation & Amortization | -54.36% | -44.89% | -39.80% | -40.35% | -41.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.82% | -27.98% | -12.59% | 0.02% | 30.32% |
| Operating Income | 31.82% | 27.98% | 12.59% | -0.02% | -30.32% |
| Income Before Tax | 30.69% | 27.80% | 12.42% | 0.03% | -29.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.69% | 27.80% | 12.42% | 0.03% | -29.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.69% | 27.80% | 12.42% | 0.03% | -29.99% |
| EBIT | 31.82% | 27.98% | 12.59% | -0.02% | -30.32% |
| EBITDA | 31.81% | 27.97% | 12.57% | -0.05% | -30.40% |
| EPS Basic | 63.13% | 51.12% | 33.53% | 15.91% | -15.80% |
| Normalized Basic EPS | 63.27% | 51.12% | 33.53% | 15.91% | -15.80% |
| EPS Diluted | 63.13% | 51.12% | 33.53% | 15.91% | -15.80% |
| Normalized Diluted EPS | 63.27% | 51.12% | 33.53% | 15.91% | -15.80% |
| Average Basic Shares Outstanding | 192.74% | 69.16% | 35.96% | 20.99% | 14.04% |
| Average Diluted Shares Outstanding | 192.74% | 69.16% | 35.96% | 20.99% | 14.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |